Mr Žilvinas Kvietkus > Cobalt > Vilnius, Lithuania > Lawyer Profile

The IP team at Cobalt is significantly active in the field of pharmaceutical IP work and it receives a steady workflow in regulatory, IP transactions, trademark and design prosecution, and IP enforcement work. Intellectual property, information technologies and data protection remain core areas for the team, with the practice regularly advising global players in these markets. The team has been engaged by various clients to advise on the management of their trademark portfolios, with a strong track record of successful outcomes in trademark and patent-related disputes. The team is led by Žilvinas Kvietkus, who has a well-established practice in the areas of life sciences and pharmaceutical law, handling a range of related intellectual property and dispute resolution work in these sectors.

Cobalt‘s team, comprising both the corporate and M&A and commercial practices, handles some of the most prominent transactions in the region. With specialties in renewable energy, deep technology, agriculture, e-commerce, healthcare, and financial services, the practice is able to draw upon a wide and varied experience when handling client matters. The team provides advice to majority shareholders on sales, and both the targets and purchasers on major M&A transactions and share purchase agreements. The team is jointly led by Irmantas Norkus, who has extensive experience in private and public M&A transactions, and Elijus Burgis , who heads the firm’s corporate transactions department. Further, Juozas Rimas specialises in private equity M&A deals, and Žilvinas Kvietkus has a well-established practice and reputation in the areas of life sciences and pharmaceutical law.

Cobalt‘s TMT team, as a part of its general commercial law department, is continuously engaged to handle a variety of matters across the practice area. The practice group offers a wide range of legal services from advising on regulatory compliance and legal environment matters, to handling large mandates brought by global companies involving new media or new technologies. The team is led by practice head Žilvinas Kvietkus, who has particular expertise in the life sciences and pharmaceutical sectors.